Status:
COMPLETED
Pilot Dispensing Evaluation of a Plus Power Lens
Lead Sponsor:
Johnson & Johnson Vision Care, Inc.
Conditions:
Hyperopia
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the performance of the ACUVUE® ADVANCE® Plus lenses against ACUVUE® ADVANCE® lenses in the plus power parameters.
Eligibility Criteria
Inclusion
- The subject must be at least 18 years of age and no more than 45 years of age.
- The subject is a current spherical soft contact lens wearer and willing to wear the study lenses on a daily wear basis for the duration of the study (defined as a minimum of 6 hours with a minimum of at least 1 month's wear prior to the study).
- The subject's optimal verified spherical equivalent distance correction must be between +1.00 and + 6.00D.
- Any cylinder power must be ≤ 0.75D.
- The subject must have visual acuity best correctable to 20/25+3 or better for each eye.
- The subject must read and sign the Statement of Informed Consent.
- The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol.
Exclusion
- Ocular or systemic allergies or disease which might interfere with contact lens wear.
- Systemic disease or use of medication which might interfere with contact lens wear.
- Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear.
- Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
- Any ocular infection.
- Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
- Pregnancy or lactation.
- Diabetes.
- Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
- Habitual contact lens type is toric, bifocal, in monovision contact lens wear, or is worn as extended wear.
- Need any near correction.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT01228591
Start Date
October 1 2010
End Date
November 1 2010
Last Update
June 19 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Winter Park, Florida, United States
2
New York, New York, United States
3
Nanticoke, Pennsylvania, United States